2023
DOI: 10.1039/d3tb00720k
|View full text |Cite
|
Sign up to set email alerts
|

A novel Gd3+ DTPA-bisamide complex with high relaxivity as an MRI contrast agent

Abstract: A novel Gd(iii) complex-based MRI contrast agent GdL has been designed and synthesized, which exhibited a much higher relaxivity than the commercially used Magnevist®, good water solubility, excellent stability, high biosafety and biocompatibility.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
0
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
4

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
references
References 34 publications
0
0
0
Order By: Relevance